Grantstown, Ireland

Seamus O'Reilly

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seamus O'Reilly. Retrieved from https://idiyas.com/inventor/seamus-o-reilly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seamus O'Reilly: Innovator in Cancer Treatment

Introduction

Seamus O'Reilly is a notable inventor based in Grantstown, Ireland. He has made significant contributions to the field of cancer treatment through his innovative research and development.

Latest Patents

O'Reilly holds a patent for a compound, composition, and method for treating cancer. His patent, titled "Substantially pure 3,5-dichloro-2-methoxy-4-hydroxy-6-(trichloromethyl)pyridine or 4-demethylpenclomedine," includes acid addition salts and pharmaceutical compositions containing the compound. The method disclosed in the patent outlines the use of this compound in the treatment of cancer in mammals.

Career Highlights

Throughout his career, O'Reilly has focused on developing effective treatments for cancer. His dedication to research has led to the successful patenting of his innovative compound, which has the potential to improve cancer treatment outcomes.

Collaborations

O'Reilly has collaborated with notable colleagues, including Neil Hartman and Robert F Struck. These partnerships have contributed to the advancement of his research and the development of his patented treatment.

Conclusion

Seamus O'Reilly's work in cancer treatment exemplifies the impact of innovation in medicine. His patented compound represents a significant step forward in the fight against cancer, showcasing his commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…